IL ‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID ‐19 patients
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Hossein M Elbadawy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah, Saudi Arabia. Hauptthemen laut MEDLINE: COVID-19, Interleukin-10. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education in Saudi Arabia.
Abstract (Originalsprache)
Introduction
The management of hospitalized COVID‐19 patients depends largely on controlling the intensified inflammatory response known as the cytokine storm. Candidate inflammatory cytokines can serve as new biomarkers for the management of hospitalized COVID‐19 patients.
Methods
Patients (80) were recruited into three groups: room air (RA), oxygen (OX) and mechanical ventilator (MV). Blood analysis was performed for RBC, WBC, Hb, Platelets, serum albumin and creatinine, INR, PTT, and hematocrit. ELISA was used to quantify a panel of inflammatory mediators including GM‐SCF, IFN‐α, IFNγ, IL‐1β, IL‐1R, IL‐2, IL‐2Ra, IL‐6, IL‐8, IL‐10, IL‐12p70, IL‐13, MCP‐1, MIP‐1a, and TNF‐α. Correlations between laboratory results and the levels of circulating inflammation mediators were investigated.
Results
Patients on MV had low RBC, Hb, albumin, and HCT and high WBC count, PTT, and INR when compared to RA and OX groups. A statistical positive correlation was found between WBC and the levels of IL‐6 and MCP‐1. RBCs correlated negatively with IL‐6 and IL‐10 and positively with IL‐8. Higher TNF‐α correlated with lower platelet counts while higher levels of IL‐1Rα and IL‐10 were associated with lower Hb levels. Increases in IFN‐γ and TNF‐α were indicative of compromised kidney functions as creatinine levels increased significantly. Most significant correlations were found between IL‐6 and lab results, showing positive correlation with WBC and INR, and negative correlation with RBC, albumin, and HCT.
Conclusions
Having the most significant correlations, IL‐6 high levels in mechanically ventilated patients were shown to affect laboratory results, and, therefore, is suggested as a severity biomarker of COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah, Saudi Arabia.
- Ohud Hospital, Madinah, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
- Department of Pharmacy, Ohud Hospital, Madinah, Saudi Arabia.
- Department of Nursing, Ohud Hospital, Madinah, Saudi Arabia.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt.
ORCID-Profile: Hossein M Elbadawy
Förderung
- Ministry of Education in Saudi Arabia
Zitieren
APA
Elbadawy, H. M., Khattab, A., El-Agamy, D. S., Eltahir, H. M., Alhaddad, A., Aljohani, F. D., Almuzaini, T. M., Abouzied, M. M., & Aldhafiri, A. (2023). IL ‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID ‐19 patients. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24881
Vancouver
Elbadawy HM, Khattab A, El-Agamy DS, Eltahir HM, Alhaddad A, Aljohani FD, et al. IL ‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID ‐19 patients. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24881
BibTeX
@article{Elbadawy2023,
author = {Elbadawy, Hossein M and Khattab, Amin and El-Agamy, Dina S and Eltahir, Heba M and Alhaddad, Aisha and Aljohani, Fahad Dakilallah and Almuzaini, Tarraji Mohammed and Abouzied, Mekky M and Aldhafiri, Ahmed},
title = {IL ‐6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID ‐19 patients},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24881}
}
EUVIMED